Original Articles
Vol. 18 No. 3 (2024)
Outcomes of middle meningeal artery embolization for treating chronic subdural hematoma
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Published: 3 July 2024
3945
Views
1203
Downloads
730
HTML
Authors
The study evaluates chronic subdural hematoma (cSDH) middle meningeal artery (MMA) embolization efficacy and safety. A prospective interventional study was conducted in Viet Duc Hospital from November 2021 to April 2024. All consecutive cSDH MMA embolization patients were included. Clinical and imaging data were collected before and one month after treatment. The study included 31 42-cSDH patients. Of these, 25.8% had hematoma evacuation, 83.9% were treated with surgery and embolization, and 16.1% with embolization alone. 92.9% of procedures used polyvinyl alcohol particles. The success rate was 92.9% and complications 7.1%. Asymptomatic external carotid artery vasospasm and MMA rupture occurred. Functional improvement occurred in 91.7% of patients one month after treatment. Significantly lower mean modified Rankin Scale (mRS) score (0.2±0.7 vs. 1.7±0.9; P=0.000) and higher proportion of patients with ≤2 mRS score (95.8% vs. 74.1%) were observed after treatment. Hematoma thickness decreased significantly (P=0.00) from 21.5±7.9 mm to 8.3±4.1 mm. The midline shift decreased significantly from 7.4±5.0 mm to 0.7±1.2 mm (P=0.00). Just one patient (4.2%) needed surgery. MMA embolization alone or with surgery appears to treat cSDH safely and effectively.
Downloads
Download data is not yet available.
Citations
Yang W, Huang J. Chronic subdural hematoma: epidemiology and natural history. Neurosurg Clin N Am 2017;28:205-10.
Blaauw J, Jacobs B, Hertog HM den, et al. Mortality after chronic subdural hematoma is associated with frailty. Acta Neurochir 2022;164:3133-41.
Edlmann E, Giorgi-Coll S, Whitfield PC, et al. Pathophysiology of chronic subdural haematoma: inflammation, angiogenesis and implications for pharmacotherapy. J Neuroinflammation 2017;14:108.
Ivamoto HS, Lemos HP, Atallah AN. Surgical treatments for chronic subdural hematomas: a comprehensive systematic review. World Neurosurg 2016;86:399-418.
Fiorella D, Arthur AS. Middle meningeal artery embolization for the management of chronic subdural hematoma. J Neurointerv Surg 2019;11:912-5.
Yang W, Huang J. Chronic subdural hematoma: epidemiology and natural history. Neurosurg Clin N Am 2017;28:205-10.
Hashimoto T, Ohashi T, Watanabe D, et al. Usefulness of embolization of the middle meningeal artery for refractory chronic subdural hematomas. Surg Neurol Int 2013;4:104.
Pouvelle A, Pouliquen G, Premat K, et al. Larger middle meningeal arteries on computed tomography angiography in patients with chronic subdural hematomas as compared with matched controls. J Neurotrauma 2020;37:2703-8.
Takizawa K, Sorimachi T, Ishizaka H, et al. Enlargement of the middle meningeal artery on MR angiography in chronic subdural hematoma. J Neurosurg 2016;124:1679-83.
Salem MM, Kuybu O, Nguyen Hoang A, et al. Middle meningeal artery embolization for chronic subdural hematoma: predictors of clinical and radiographic failure from 636 embolizations. Radiology 2023;307:e222045.
Krothapalli N, Patel S, Fayad M, et al. Outcomes of particle versus liquid embolic materials used in middle meningeal artery embolization for the treatment of chronic subdural hematoma. World Neurosurg 2023;173:e27-e36.
Shehabeldin M, Amllay A, Jabre R, et al. Onyx Versus particles for middle meningeal artery embolization in chronic subdural hematoma. Neurosurgery 2023;92:979-85.
Kan P, Maragkos GA, Srivatsan A, et al. Middle Meningeal artery embolization for chronic subdural hematoma: a multi-center experience of 154 consecutive embolizations. neurosurgery. 2021;88:268-77.
Gomez-Paz S, Akamatsu Y, Salem MM, et al. Upfront middle meningeal artery embolization for treatment of chronic subdural hematomas in patients with or without midline shift. Interv Neuroradiol 2021;27:571-6.
Tempaku A, Yamauchi S, Ikeda H, et al. Usefulness of interventional embolization of the middle meningeal artery for recurrent chronic subdural hematoma: Five cases and a review of the literature. Interv Neuroradiol 2015;21:366.
Link TW, Schwarz JT, Paine SM, et al. Middle Meningeal Artery Embolization for Recurrent Chronic Subdural Hematoma: A Case Series. World Neurosurg 2018;118:e570-e574.
Shotar E, Meyblum L, Premat K, et al. Middle meningeal artery embolization reduces the post-operative recurrence rate of at-risk chronic subdural hematoma. J Neurointerv Surg 2020;12:1209-13.
Lam A, Selvarajah D, Htike SS, et al. The efficacy of postoperative middle meningeal artery embolization on chronic subdural hematoma - A multicentered randomized controlled trial. Surg Neurol Int 2023;14:168.
Ng S, Derraz I, Boetto J, et al. Middle meningeal artery embolization as an adjuvant treatment to surgery for symptomatic chronic subdural hematoma: a pilot study assessing hematoma volume resorption. J Neuro Interv Surg 2020;12:695-99.
Srivatsan A, Mohanty A, Nascimento FA, et al. Middle meningeal artery embolization for chronic subdural hematoma: meta-analysis and systematic review. World Neurosurg 2019;122:613-9.
Waqas M, Vakhari K, Weimer PV, et al. Safety and effectiveness of embolization for chronic subdural hematoma:
systematic review and case series. World Neurosurg 2019;126:228-36.
Court J, Touchette CJ, Iorio-Morin C, et al. Embolization of the Middle meningeal artery in chronic subdural hematoma - A systematic review. Clin Neurol Neurosurg 2019;186:105464.
Di Cristofori A, Remida P, Patassini M, et al. Middle meningeal artery embolization for chronic subdural hematomas. A systematic review of the literature focused on indications, technical aspects, and future possible perspectives. Surg Neurol Int 2022;13:94.
Ironside N, Nguyen C, Do Q, et al. Middle meningeal artery embolization for chronic subdural hematoma: a systematic review and meta-analysis. J Neurointerv Surg 2021;13:951-7.
Joyce E, Bounajem MT, Scoville J, et al. Middle meningeal artery embolization treatment of nonacute subdural hematomas in the elderly: a multiinstitutional experience of 151 cases. Neurosurg Focus 2020;49:E5.
Cannarsa GJ, Olexa J, Chryssikos T, et al. Stand-alone middle meningeal artery embolization for treatment of giant chronic subdural hematoma in elderly frail patients: a case series. Neurosurgery 2021;89:S6.
Jumah F, Osama M, Islim AI, et al. Efficacy and safety of middle meningeal artery embolization in the management of refractory or chronic subdural hematomas: a systematic review and meta-analysis. Acta Neurochir (Wien) 2020;162:499-507.
How to Cite
Outcomes of middle meningeal artery embolization for treating chronic subdural hematoma. (2024). Italian Journal of Medicine, 18(3). https://doi.org/10.4081/itjm.2024.1759
Copyright (c) 2024 the Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Most read articles by the same author(s)
- Bui Quang Huynh, Nguyen Duy Hung, Le Thanh Dung, Nguyen-Thi Thu, Nguyen-Thi Hai Anh, Ngo Quang Duy, Nguyen Minh Duc, The value of computed tomography perfusion for assessing the response of hepatocellular carcinoma to transarterial chemoembolization , Italian Journal of Medicine: Vol. 18 No. 3 (2024)